Liver Abscess



Bacterial abscess of the liver is relatively rare; however, it has been described since the time of Hippocrates (400 BC), with the first published review by Bright appearing in 1936. In 1938, Ochsner's classic review heralded surgical drainage as the definitive therapy; however, despite the more aggressive approach to treatment, the mortality remained at 60-80%.[1]

The development of new radiologic techniques, the improvement in microbiologic identification, and the advancement of drainage techniques, as well as improved supportive care, have reduced mortality to 5-30%; yet, the prevalence of liver abscess has remained relatively unchanged. Untreated, this infection remains uniformly fatal.

The three major forms of liver abscess, classified by etiology, are as follows:

For patient education resources, see the Infections Center and the Digestive Disorders Center, as well as Skin Abscess and Antibiotics.


The liver receives blood from both systemic and portal circulations. Increased susceptibility to infections would be expected given the increased exposure to bacteria. However, Kupffer cells lining the hepatic sinusoids clear bacteria so efficiently that infection rarely occurs. Multiple processes have been associated with the development of hepatic abscesses (see the image below).

View Image

Table 4: Underlying etiology of 1086 cases of liver abscess compiled from the literature.

Appendicitis was traditionally the major cause of liver abscess. As diagnosis and treatment of this condition has advanced, its frequency as a cause for liver abscess has decreased to 10%.

Biliary tract disease is now the most common source of pyogenic liver abscess (PLA). Obstruction of bile flow allows for bacterial proliferation. Biliary stone disease, obstructive malignancy affecting the biliary tree, stricture, and congenital diseases are common inciting conditions. With a biliary source, abscesses usually are multiple, unless they are associated with surgical interventions or indwelling biliary stents. In these instances, solitary lesions can be seen.

Infections in organs in the portal bed can result in a localized septic thrombophlebitis, which can lead to liver abscess. Septic emboli are released into the portal circulation, trapped by the hepatic sinusoids, and become the nidus for microabscess formation. These microabscesses initially are multiple but usually coalesce into a solitary lesion.

Microabscess formation can also be due to hematogenous dissemination of organisms in association with systemic bacteremia, such as endocarditis and pyelonephritis. Cases also are reported in children with underlying defects in immunity, such as chronic granulomatous disease and leukemia.

Approximately 4% of liver abscesses result from fistula formation between local intra-abdominal infections.

Despite advances in diagnostic imaging, cryptogenic causes account for a significant proportion of cases; surgical exploration has impacted this minimally. These lesions usually are solitary in nature.

Penetrating hepatic trauma can inoculate organisms directly into the liver parenchyma, resulting in pyogenic liver abscess. Nonpenetrating trauma can also be the precursor to pyogenic liver abscess by causing localized hepatic necrosis, intrahepatic hemorrhage, and bile leakage. The resulting tissue environment permits bacterial growth, which may lead to pyogenic liver abscess. These lesions are typically solitary.

PLA has been reported as a secondary infection of amebic abscess, hydatid cystic cavities, and metastatic and primary hepatic tumors. It is also a known complication of liver transplantation, hepatic artery embolization in the treatment of hepatocellular carcinoma, and the ingestion of foreign bodies, which penetrate the liver parenchyma. Trauma and secondarily infected liver pathology account for a small percentage of liver abscess cases.

The right hepatic lobe is affected more often than the left hepatic lobe by a factor of 2:1. Bilateral involvement is seen in 5% of cases. The predilection for the right hepatic lobe can be attributed to anatomic considerations. The right hepatic lobe receives blood from both the superior mesenteric and portal veins, whereas the left hepatic lobe receives inferior mesenteric and splenic drainage. It also contains a denser network of biliary canaliculi and, overall, accounts for more hepatic mass. Studies have suggested that a streaming effect in the portal circulation is causative.


Polymicrobial involvement is common, with Escherichia coli and Klebsiella pneumoniae being the two most frequently isolated pathogens (see the image below). Reports suggest that K pneumoniae is an increasingly prominent cause.[4]

View Image

Table 2: Microbiologic results from 312 cases of liver abscess compiled from the literature.

Enterobacteriaceae are especially prominent when the infection is of biliary origin. Abscesses involving K pneumoniae have been associated with multiple cases of endophthalmitis.

The pathogenic role of anaerobes was underappreciated until the isolation of anaerobes from 45% of cases of pyogenic liver abscess was reported in 1974. Since that time, increasing rates of anaerobic involvement have been reported, likely because of increased awareness and improved culturing techniques. The most frequently encountered anaerobes are Bacteroides species, Fusobacterium species, and microaerophilic and anaerobic streptococci. A colonic source is usually the initial source of infection.

Staphylococcus aureus abscesses usually result from hematogenous spread of organisms involved with distant infections, such as endocarditis. S milleri is neither anaerobic nor microaerophilic. It has been associated with both monomicrobial and polymicrobial abscesses in patients with Crohn disease, as well as with other patients with pyogenic liver abscess.

Amebic liver abscess is most often due to E histolytica. Liver abscess is the most common extraintestinal manifestation of this infection.

Fungal abscesses primarily are due to Candida albicans and occur in individuals with prolonged exposure to antimicrobials, hematologic malignancies, solid-organ transplants, and congenital and acquired immunodeficiency. Cases involving Aspergillus species have been reported.

Other organisms reported in the literature include Actinomyces species, Eikenella corrodens, Yersinia enterocolitica, Salmonella typhi, and Brucella melitensis.

A small case series in Taiwan investigated pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. In regions with a high prevalence of both pyogenic liver abscess and hepatocellular carcinoma, clinicians should be aware of the possibility of underlying hepatocellular carcinoma in patients with risk factors for the disease.[5]


United States statistics

The incidence of pyogenic liver abscess has essentially remained unchanged by both hospital and autopsy data. Liver abscess was diagnosed in 0.7%, 0.45%, and 0.57% of autopsies during the periods of 1896-1933, 1934-1958, and 1959-1968, respectively. The frequency in hospitalized patients is in the range of 8-16 cases per 100,000 persons. Studies suggest a small, but significant, increase in the frequency of liver abscess.

Age-related demographics

Prior to the antibiotic era, liver abscess was most common in the fourth and fifth decades of life, primarily due to complications of appendicitis. With the development of better diagnostic techniques, early antibiotic administration, and the improved survival of the general population, the demographic has shifted toward the sixth and seventh decades of life. Frequency curves display a small peak in the neonatal period followed by a gradual rise beginning at the sixth decade of life.

Cases of liver abscesses in infants have been associated with umbilical vein catheterization and sepsis.

When abscesses are seen in children and adolescents, underlying immune deficiency, severe malnutrition, or trauma frequently exists.

Sex-related demographics

While abscesses once showed a predilection for males in earlier decades, no sexual predilection currently exists. Males have a poorer prognosis from hepatic abscess than females.


Untreated, pyogenic liver abscess remains uniformly fatal. With timely administration of antibiotics and drainage procedures, mortality currently occurs in 5-30% of cases. The most common causes of death include sepsis, multiorgan failure, and hepatic failure.[3]

Indicators of a poor prognosis have been described since 1938 and include multiplicity of abscesses, underlying malignancy, severity of underlying medical conditions, presence of complications, and delay in diagnosis.[3]

Indicators of a poor prognosis in amebic abscess include a bilirubin level of greater than 3.5 mg/dL, encephalopathy, hypoalbuminemia (ie, serum albumin level of <2 g/dL), and multiple abscesses; all are independent factors that predict poor outcome.

An underlying malignant etiology and an Acute Physiology and Chronic Health Evaluation (APACHE II) score greater than 9 increases the relative mortality by 6.3-fold and 6.8-fold, respectively.

Chen et al examined prognostic factors for elderly patients with pyogenic liver abscess.[9] Results from the study, which included 118 patients aged 65 years or older and 221 patients below age 65 years, indicated that age and an APACHE II score of 15 or greater at hospital admission were risk factors for mortality. The evidence ultimately suggested that outcomes for older patients with pyogenic liver abscess are on a par with those for younger patients. The investigators also found that in the younger patient group, there was greater frequency of males suffering from alcoholism, a cryptogenic abscess, and K pneumoniae infection.


The most frequent symptoms of hepatic abscess include the following (see the image below):

View Image

Table 1: Presenting symptoms and signs in 715 patients diagnosed with liver abscess.

Cough or hiccoughs due to diaphragmatic irritation may be reported. Referred pain to the right shoulder may be present.

Individuals with solitary lesions usually have a more insidious course with weight loss and anemia of chronic disease. With such symptoms, malignancy often is the initial consideration.

Fever of unknown origin (FUO) frequently can be an initial diagnosis in indolent cases. Multiple abscesses usually result in more acute presentations, with symptoms and signs of systemic toxicity.

Afebrile presentations have been documented.

Physical Examination

Fever and tender hepatomegaly are the most common signs. A palpable mass need not be present. Midepigastric tenderness, with or without a palpable mass, is suggestive of left hepatic lobe involvement.

Decreased breath sounds in the right basilar lung zones, with signs of atelectasis and effusion on examination or radiologically, may be present. A pleural or hepatic friction rub can be associated with diaphragmatic irritation or inflammation of Glisson capsule.

Jaundice may be present in as many as 25% of cases and usually is associated with biliary tract disease or the presence of multiple abscesses.


Complications of liver abscess may include the following:

Laboratory Studies

Laboratory studies may include a complete blood count (CBC) with differential (to identify anemia of chronic disease or neutrophilic leukocytosis) and liver function studies (hypoalbuminemia and elevation of alkaline phosphatase are the most common abnormalities; elevations of transaminase and bilirubin levels are variable.

Blood cultures are positive in roughly 50% of cases. Culture of abscess fluid should be the goal in establishing microbiologic diagnosis.

Enzyme immunoassay should be performed to detect E histolytica in patients either from endemic areas or who have traveled to endemic areas.

Imaging Studies

Advances in radiologic techniques has been credited with the improvement in mortality. The various radiologic techniques have differing benefits and limitations with regard to their diagnostic utility (see the image below).

View Image

Table 3: Comparison of the radiologic procedures used in the diagnosis of liver abscess.

Computed tomography

Computed tomography (CT) with contrast and ultrasonography remain the radiologic modalities of choice as screening procedures and also can be used as techniques for guiding percutaneous aspiration and drainage.

With advancements in multidetector CT scan technology, image quality has improved dramatically, allowing improved detection. CT has a sensitivty of 95-100% in this setting (see the images below).

View Image

Computed tomography (CT) scan findings of liver abscess are shown. A large, septated abscess of the right hepatic lobe is revealed. Abscess was succes....

View Image

Computed tomography (CT) scan findings of liver abscess are shown. A large anterior abscess involving the left hepatic lobe is revealed. Abscess was s....

Lesions on CT evaluation are well-demarcated areas hypodense to the surrounding hepatic parenchyma. Peripheral enhancement is seen when intravenous (IV) contrast is administered. Gas can be seen in as many as 20% of lesions.

CT is superior in its ability to detect lesions less than 1 cm. This technique also enables evaluation for an underlying concurrent pathology throughout the abdomen and pelvis. Indium-labeled white blood cell (WBC) scans are somewhat more sensitive in this regard.

A retrospective study was undertaken using patient records from a group of 131 patients with confirmed pyogenic liver abscesses to determine CT scan characteristics of those abscesses caused by monomicrobial K pneumoniae infection versus other causes. A comparison was performed between the K pneumoniae liver abscess patients and a comparison group. Notably, only 70.2% of the cases were determined to be monomicrobial K pneumoniae liver abscesses. CT scan characteristics more likely to be seen in these monomicrobial liver abscesses were (1) a single abscess, (2) unilobar involvement, (3) solid appearance, (4) association with thrombophlebitis, and (5) hematogenous appearance.[6]


Ultrasonographic evaluation (sensitivity, 80-90%) reveals hypoechoic masses with irregularly shaped borders. Internal septations or cavity debris may be detected.[7]  It allows close evaluation of the biliary tree and simultaneous aspiration of the cavity. The major benefits of this modality are its portability and diagnostic utility in patients who are too critical to undergo prolonged radiologic evaluation or to be moved out of monitored setting. Operator dependence affects its overall sensitivity.

Radionuclide scanning

The initial studies are used in diagnosis.[8]  Gallium and technetium radionuclide scanning use the fact that the radiopharmaceuticals share the same uptake, transport, and excretion pathways as bilirubin and, thus, are effective agents in evaluating liver disease. Sensitivity varies with the radiopharmaceutical utilized, technetium (80%), gallium (50-80%), and indium (90%). Limitations include a delay in diagnosis and the need for confirmatory procedures; thus, they offer no benefit over other imaging modalities.

Chest radiography

Chest radiographic findings of basilar atelectasis, right hemidiaphragm elevation, and right pleural effusion are present in approximately 50% of cases; before advancements in radiologic technique, these served as diagnostic clues. Pneumonias or pleural diseases often are initially considered because of the radiographic findings.

Percutaneous Aspiration and Drainage

Percutaneous needle aspiration

Under CT or ultrasonographic guidance, needle aspiration of cavity material can be performed. Needle aspiration enables rapid recovery of material for microbiologic and pathologic evaluation. It can be performed with the initial diagnostic procedure.

Percutaneous catheter drainage

Percutaneous drainage has become the standard of care and should be the first intervention considered for small cysts. Advantages include reduced costs, recovery time, and postprocedure recovery rate; it eliminates the need for general anesthesia. This also allows for gradual, controlled drainage. For cysts larger than 5 cm, ruptured cysts, and multiloculated cysts, surgical drainage is generally recommended over percutaneous intervention.

A catheter is placed under ultrasonographic or CT guidance via the Seldinger or trocar techniques. The catheter is flushed daily until output is less than 10 mL/day or cavity collapse is documented by serial CT.

Multiple abscesses have been drained successfully by this method. Failure to respond to catheter drainage is the main reported complication and is also an indication for surgical intervention. Other complications reported (rarely) are bleeding at the catheter site, perforation of hollow viscus, and peritonitis from intraperitoneal spillage of cavity fluid.

Contraindications include coagulopathy; a difficult access path to the cavity; peritonitis; and/or a complicated, multiloculated, thick-walled abscess with viscous pus.

Medical Care

An untreated hepatic abscess is nearly uniformly fatal as a result of complications that include sepsis, empyema, or peritonitis from rupture into the pleural or peritoneal spaces, and retroperitoneal extension. Treatment should include drainage, either percutaneous or surgical.

Antibiotic therapy as a sole treatment modality is not routinely advocated, though it has been successful in a few reported cases. It may be the only alternative in patients too ill to undergo invasive procedures or in those with multiple abscesses not amenable to percutaneous or surgical drainage. In these instances, patients are likely to require many months of antimicrobial therapy with serial imaging and close monitoring for associated complications.

Antimicrobial treatment is a common adjunct to percutaneous or surgical drainage.

Surgical Care

Surgical drainage was the standard of care until the introduction of percutaneous drainage techniques in the mid-1970s. With the refinement of image-guided techniques, percutaneous drainage and aspiration have become the standard of care.

Current indications for the surgical treatment of pyogenic liver abscess are for the treatment of underlying intra-abdominal processes, including signs of peritonitis; existence of a known abdominal surgical pathology (eg, diverticular abscess); failure of previous drainage attempts; and the presence of a complicated, multiloculated, thick-walled abscess with viscous pus.

Shock with multisystem organ failure is a contraindication for surgery.

Open surgery can be performed by either of the following two approaches:

A laparoscopic approach is also commonly used in select cases. This minimally invasive approach affords the opportunity to explore the entire abdomen and to significantly reduce patient morbidity. A growing literature is defining the optimal population for this mode of intervention.

A retrospective chart review compared surgery versus percutaneous drainage for liver abscesses greater than 5 cm. Morbidity was comparable for the two procedures, but those treated with surgery had fewer secondary procedures and fewer treatment failures.

Postoperative complications are not uncommon and include recurrent pyogenic liver abscess, intra-abdominal abscess, hepatic or renal failure, and wound infection.


Obtain an interventional radiology consultation as soon as the diagnosis is considered to allow rapid collection of cavity fluid and the potential for early therapeutic drainage of abscess.

Immediately seek a consultation with a general surgeon if the source of the abscess is a known underlying abdominal pathology or in cases with peritonitis. In cases undergoing percutaneous drainage, seek the involvement of a general surgeon if drainage of the abscess cavity is unsuccessful.

Gastroenterology involvement may be useful after successful drainage to evaluate for underlying gastrointestinal disease using colonoscopy or endoscopic retrograde cholangiopancreatography (ERCP).

Infectious disease consultation should be considered in complicated cases and when the involved pathogens are unusual or difficult to treat, such as in fungal abscesses.

Long-Term Monitoring

Aggressively seek an underlying source of the abdominal pathology.

Perform weekly serial computed tomography (CT) or ultrasound examinations to document adequate drainage of the abscess cavity. Continue radiologic evaluation to document progress of therapy after discharge.

Drain care may be required. Maintain drains until the output is less than 10 mL/day.

Monitor fever curves. Persistent fever after 2 weeks of therapy may indicate the need for more aggressive drainage.

For patients with an underlying malignancy, definitive treatment, such as surgical removal of the mass, should be pursued if at all possible.

Patients will require prolonged parenteral antimicrobial therapy that may continue after discharge. Monitoring of medication levels, renal function, and blood counts may be needed. Enteral nutrition is the preferred route unless it is clinically contraindicated.

Medication Summary

Until cultures are available, the choice of antimicrobial agents should be directed toward the most commonly involved pathogens. Regimens using beta-lactam/beta-lactamase inhibitor combinations, carbapenems, or second-generation cephalosporins with anaerobic coverage are excellent empiric choices for the coverage of enteric bacilli and anaerobes. Metronidazole or clindamycin should be added for the coverage of Bacteroides fragilis if other employed antibiotics offer no anaerobic coverage.

Amebic abscess should be treated with metronidazole, which will be curative in 90% of cases. Metronidazole should be initiated before serologic test results are available. Patients who do not respond to metronidazole should receive chloroquine alone or in combination with emetine or dehydroemetine.

Systemic antifungal agents should be initiated if fungal abscess is suspected and after the abscess has been drained percutaneously or surgically. Initial therapy for fungal abscess is currently amphotericin B. Lipid formulations may offer some benefit in that the complexing of drug to lipid moieties allows for concentration in hepatocytes. Further investigation is required for definitive proof. Cases of successful fluconazole treatment after amphotericin failure have been reported; however, its use as an initial agent is still being studied.

Ultimately, the organisms isolated and antibiotic sensitivities should guide the final choice of antimicrobials.

Duration of treatment has always been debated. Short courses (2 wk) of therapy after percutaneous drainage have been successful in a small series of patients; however, most series have reported recurrence of abscess even after more prolonged courses. Currently 4-6 weeks of therapy is recommended for solitary lesions that have been adequately drained. Multiple abscesses are more problematic and can require up to 12 weeks of therapy. Both the clinical and radiographic progress of the patient should guide the length of therapy.

Meropenem (Merrem)

Clinical Context:  Bactericidal broad-spectrum carbapenem antibiotic that inhibits cell-wall synthesis. Effective against most gram-positive and gram-negative bacteria.

Has slightly increased activity against gram negatives and slightly decreased activity against staphylococci and streptococci species compared to imipenem.

Imipenem and cilastatin (Primaxin)

Clinical Context:  For treatment of multiple organism infections in which other agents do not have wide-spectrum coverage or are contraindicated due to potential for toxicity.

Cefuroxime (Ceftin)

Clinical Context:  Second-generation cephalosporin maintains gram-positive activity that first-generation cephalosporins have; adds activity against Proteus mirabilis, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, and Moraxella catarrhalis. Condition of patient, severity of infection, and susceptibility of microorganism determine proper dose and route of administration.

Cefotetan (Cefotan)

Clinical Context:  Second-generation cephalosporin indicated for infections caused by susceptible gram-positive cocci and gram-negative rods.

Dosage and route of administration depends on condition of patient, severity of infection, and susceptibility of causative organism.

Cefoxitin (Mefoxin)

Clinical Context:  Second-generation cephalosporin indicated for gram-positive cocci and gram-negative rod infections. Infections caused by cephalosporin-resistant or penicillin-resistant gram-negative bacteria may respond to cefoxitin.

Cefaclor (Ceclor)

Clinical Context:  Second-generation cephalosporin indicated for infections caused by susceptible gram-positive cocci and gram-negative rods.

Determine proper dosage and route based on condition of patient, severity of infection, and susceptibility of causative organism.

Clindamycin (Cleocin)

Clinical Context:  Lincosamide for treatment of serious skin and soft tissue staphylococcal infections. Also effective against aerobic and anaerobic streptococci (except enterococci). Inhibits bacterial growth, possibly by blocking dissociation of peptidyl t-RNA from ribosomes causing RNA-dependent protein synthesis to arrest.

Metronidazole (Flagyl)

Clinical Context:  Imidazole ring-based antibiotic active against various anaerobic bacteria and protozoa. Used in combination with other antimicrobial agents (except for Clostridium difficile enterocolitis).

Class Summary

Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting.

Amphotericin B (AmBisome)

Clinical Context:  Produced by a strain of Streptomyces nodosus; can be fungistatic or fungicidal. Binds to sterols, such as ergosterol, in the fungal-cell membrane, causing intracellular components to leak with subsequent fungal-cell death.

Fluconazole (Diflucan)

Clinical Context:  Synthetic oral antifungal (broad-spectrum bistriazole) that selectively inhibits fungal cytochrome P-450 and sterol C-14 alpha-demethylation.

Class Summary

Their mechanism of action may involve an alteration of RNA and DNA metabolism or an intracellular accumulation of peroxide that is toxic to the fungal cell.


Ruben Peralta, MD, FACS, Professor of Surgery, Anesthesia and Emergency Medicine, Senior Medical Advisor, Board of Directors, Program Chief of Trauma, Emergency and Critical Care, Consulting Staff, Professor Juan Bosch Trauma Hospital, Dominican Republic

Disclosure: Nothing to disclose.


Michelle V Lisgaris, MD, Assistant Professor of Medicine, Case Western Reserve University School of Medicine

Disclosure: Nothing to disclose.

Robert A Salata, MD, Chief and Clinical Program Director of Division of Infectious Diseases, Vice Chair for International Affairs, Professor, Department of Medicine, Case Western Reserve University School of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Joseph F John, Jr, MD, FACP, FIDSA, FSHEA, Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MSc, MA, Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director, Surgical Research, Department of Surgery, Yale-New Haven Hospital; American Gastroenterological Association Fellow

Disclosure: Received royalty from AMGEN for consulting; Received ownership interest from Ardelyx for consulting.

Additional Contributors

Marco G Patti, MD, Professor of Surgery, Director, Center for Esophageal Diseases, University of Chicago Pritzker School of Medicine

Disclosure: Nothing to disclose.


  1. Ochsner A, DeBakey M, Murray S. Pyogenic Abscess of the Liver II. An Analysis of Forty-Seven Cases with Review of the Literature. Am J Surg. 1938. XL:292-319.
  2. Othman N, Mohamed Z, Yahya MM, Meng LV, Huat LB, Noordin R. Entamoeba histolytica antigenic protein detected in pus aspirates from patients with amoebic liver abscess. Exp Parasitol. 2013 May 13. [View Abstract]
  3. Chen SC, Huang CC, Tsai SJ, et al. Severity of disease as main predictor for mortality in patients with pyogenic liver abscess. Am J Surg. 2009 Aug. 198(2):164-72. [View Abstract]
  4. Brisse S, Fevre C, Passet V, et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One. 2009. 4(3):e4982. [View Abstract]
  5. Lin YT, Liu CJ, Chen TJ, Chen TL, Yeh YC, Wu HS, et al. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med. 2011 Dec. 124(12):1158-64. [View Abstract]
  6. Alsaif HS, Venkatesh SK, Chan DS, Archuleta S. CT Appearance of Pyogenic Liver Abscesses Caused by Klebsiella pneumoniae. Radiology. 2011 Jul. 260(1):129-38. [View Abstract]
  7. Fontanilla T, Noblejas A, Cortes C, Minaya J, Mendez S, Van den Brule E, et al. Contrast-enhanced ultrasound of liver lesions related to arterial thrombosis in adult liver transplantation. J Clin Ultrasound. 2013 Jun 6. [View Abstract]
  8. Cavailloles FA, Mure A, Nasser H, Lecapitaine AL, Granier F. Multiple Liver Amoebic Abscesses Detected on FDG PET/CT. Clin Nucl Med. 2013 May 1. [View Abstract]
  9. Chen SC, Lee YT, Yen CH, et al. Pyogenic liver abscess in the elderly: clinical features, outcomes and prognostic factors. Age Ageing. 2009 May. 38(3):271-6; discussion. [View Abstract]
  10. Bahloul M, Chaari A, Bouaziz-Khlaf N, et al. Multiple pyogenic liver abscess. World J Gastroenterol. 2006 May 14. 12(18):2962-3. [View Abstract]
  11. Branum GD, Tyson GS, Branum MA, et al. Hepatic abscess. Changes in etiology, diagnosis, and management. Ann Surg. 1990 Dec. 212(6):655-62. [View Abstract]
  12. Burris GW, Gordon BM. Cold defect on indium leukocyte scanning of a hepatic abscess. Clin Nucl Med. 1998 Jan. 23(1):26-8. [View Abstract]
  13. Cameron JL. Hepatic abscess. Current Surgical Treatment. 8th ed. 2004. 298-303.
  14. Casado JL, Pintado V, Gomez-Mampaso E, et al. Mycobacterial liver abscess in a patient with AIDS. Postgrad Med J. 1998 Mar. 74(869):181-3. [View Abstract]
  15. Casanova C, Lorente JA, Carrillo F, et al. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med. 1989 Jun. 149(6):1467. [View Abstract]
  16. Cerwenka H, Bacher H, Werkgartner G. Treatment of patients with pyogenic liver abscess. Chemotherapy. 2005. 51:366-369.
  17. Ch Yu S, Hg Lo R, Kan PS, et al. Pyogenic liver abscess: treatment with needle aspiration. Clin Radiol. 1997 Dec. 52(12):912-6. [View Abstract]
  18. Chan KS, Yu WL, Tsai CL, et al. Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients. Chin Med J (Engl). 2007 Jan 20. 120(2):136-9. [View Abstract]
  19. Chen C, Chen PJ, Yang PM, et al. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol. 1997 Dec. 92(12):2257-9. [View Abstract]
  20. Chou FF, Sheen-Chen SM, Chen YS, et al. Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg. 1997 May. 21(4):384-8; discussion 388-9. [View Abstract]
  21. Chou FF, Sheen-Chen SM, Lee TY. Rupture of pyogenic liver abscess. Am J Gastroenterol. 1995 May. 90(5):767-70. [View Abstract]
  22. Chu KM, Fan ST, Lai EC, et al. Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg. 1996 Feb. 131(2):148-52. [View Abstract]
  23. Chung YF, Tan YM, Lui HF, et al. Management of pyogenic liver abscesses - percutaneous or open drainage?. Singapore Med J. 2007 Dec. 48(12):1158-65; quiz 1165. [View Abstract]
  24. Corredoira J, Casariego E, Moreno C, et al. Prospective study of Streptococcus milleri hepatic abscess. Eur J Clin Microbiol Infect Dis. 1998 Aug. 17(8):556-60. [View Abstract]
  25. De la Maza LM, Naceim F, Berman LD. The changing etiology of liver abscess. Further observations. JAMA. 1974 Jan 14. 227(2):161-3. [View Abstract]
  26. Doctor N, Dafnios N, Jones A, et al. Primary squamous carcinoma of liver: presentation as liver abscess. Indian J Gastroenterol. 1998 Jan. 17(1):28-9. [View Abstract]
  27. Drnovsek V, Fontanez-Garcia D, Wakabayashi MN, et al. Gastrointestinal case of the day. Pyogenic liver abscess caused by perforation by a swallowed wooden toothpick. Radiographics. 1999 May-Jun. 19(3):820-2. [View Abstract]
  28. Farges O, Leese T, Bismuth H. Pyogenic liver abscess: an improvement in prognosis. Br J Surg. 1988 Sep. 75(9):862-5. [View Abstract]
  29. Giorgio A, Tarantino L, De Stefano G. Hepatic abscess caused by Salmonella typhi: diagnosis and management by percutaneous echo-guided needle aspiration. Ital J Gastroenterol. 1996 Jan. 28(1):31-3. [View Abstract]
  30. Giorgio A, Tarantino L, Mariniello N, et al. Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance. Radiology. 1995 Apr. 195(1):122-4. [View Abstract]
  31. Gloor B, Ly Q, Candinas D. Role of laparoscopy in hepatic cyst surgery. Dig Surg. 2002. 19(6):494-9. [View Abstract]
  32. Greenwood LH, Collins TL, Yrizarry JM. Percutaneous management of multiple liver abscesses. AJR Am J Roentgenol. 1982 Aug. 139(2):390-2. [View Abstract]
  33. Haaga JR, Weinstein AJ. CT-guided percutaneous aspiration and drainage of abscesses. AJR Am J Roentgenol. 1980 Dec. 135(6):1187-94. [View Abstract]
  34. Haron E, Feld R, Tuffnell P, et al. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med. 1987 Jul. 83(1):17-26. [View Abstract]
  35. Herbert DA, Fogel DA, Rothman J, et al. Pyogenic liver abscesses: successful non-surgical therapy. Lancet. 1982 Jan 16. 1(8264):134-6. [View Abstract]
  36. Horii K, Yamazaki O, Matsuyama M, et al. Successful treatment of a hepatic abscess that formed secondary to fish bone penetration by percutaneous transhepatic removal of the foreign body: report of a case. Surg Today. 1999. 29(9):922-6. [View Abstract]
  37. Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg. 1996 May. 223(5):600-7; discussion 607-9. [View Abstract]
  38. Hughes MA, Petri WA Jr. Amebic liver abscess. Infect Dis Clin North Am. 2000 Sep. 14(3):565-82, viii. [View Abstract]
  39. Jan YY, Yeh TS, Chen MF. Cholangiocarcinoma presenting as pyogenic liver abscess: is its outcome influenced by concomitant hepatolithiasis?. Am J Gastroenterol. 1998 Feb. 93(2):253-5. [View Abstract]
  40. Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin North Am. 2000 Sep. 14(3):547-63, vii. [View Abstract]
  41. Kar P, Kapoor S, Jain A. Pyogenic liver abscess: aetiology, clinical manifestations and management. Trop Gastroenterol. 1998 Oct-Dec. 19(4):136-40. [View Abstract]
  42. Katkhouda N, Mavor E. Laparoscopic management of benign liver disease. Surg Clin North Am. 2000 Aug. 80(4):1203-11. [View Abstract]
  43. Khanna R, Levendoglu H. Liver abscess due to Yersinia enterocolitica: case report and review of the literature. Dig Dis Sci. 1989 Apr. 34(4):636-9. [View Abstract]
  44. Lamps LW, Pinson CW, Raiford DS, et al. The significance of microabscesses in liver transplant biopsies: a clinicopathological study. Hepatology. 1998 Dec. 28(6):1532-7. [View Abstract]
  45. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005 Feb. 100(2):322-31.
  46. Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med. 1986 Oct. 146(10):1913-6. [View Abstract]
  47. MacDonald GA, Greenson JK, DelBuono EA, et al. Mini-microabscess syndrome in liver transplant recipients. Hepatology. 1997 Jul. 26(1):192-7. [View Abstract]
  48. Mandel SR, Boyd D, Jaques PF, et al. Drainage of hepatic, intraabdominal, and mediastinal abscesses guided by computerized axial tomography. Successful alternative to open drainage. Am J Surg. 1983 Jan. 145(1):120-5. [View Abstract]
  49. Mathieu D, Vasile N, Fagniez PL, et al. Dynamic CT features of hepatic abscesses. Radiology. 1985 Mar. 154(3):749-52. [View Abstract]
  50. Mazza D, Gugenheim J, Toouli J, et al. Survival of a liver graft recipient treated for an aspergillar liver abscess. Clin Infect Dis. 1996 Oct. 23(4):831-2. [View Abstract]
  51. McDonald AP, Howard RJ. Pyogenic liver abscess. World J Surg. 1980 Jul. 4(4):369-80. [View Abstract]
  52. McDonald KL, Davani M. The rim sign in hepatic abscess: case report and review of the literature. J Nucl Med. 1997 Aug. 38(8):1282-3. [View Abstract]
  53. Mir-Madjlessi SH, McHenry MC, Farmer RG. Liver abscess in Crohn's disease. Report of four cases and review of the literature. Gastroenterology. 1986 Oct. 91(4):987-93. [View Abstract]
  54. Mischinger HJ, Hauser H, Rabl H, et al. Pyogenic liver abscess: studies of therapy and analysis of risk factors. World J Surg. 1994 Nov-Dec. 18(6):852-7; discussion 858. [View Abstract]
  55. Moore-Gillon JC, Eykyn SJ, Phillips I. Microbiology of pyogenic liver abscess. Br Med J (Clin Res Ed). 1981 Sep 26. 283(6295):819-21. [View Abstract]
  56. Mulholland MW, Lillemoe KD, Doherty GM. Hepatic infection and acute hepatic failure. Greenfield's Surgery Scientific Principles and Practice. 4th ed. 2006. 909-925.
  57. Perez-Cruet MJ, Grable E, Drapkin MS, et al. Pylephlebitis associated with diverticulitis. South Med J. 1993 May. 86(5):578-80. [View Abstract]
  58. Philips RL. Computed tomography and ultrasound in the diagnosis and treatment of liver abscesses. Australas Radiol. 1994 Aug. 38(3):165-9. [View Abstract]
  59. Pope IM, Poston CJ. Pyogenic liver abscess. Surgery of the Liver and Biliary Tract. 2000. 1135-1145.
  60. Quinlivan D, Davis TM, Daly FJ, et al. Hepatic abscess due to Eikenella corrodens and Streptococcus milleri: implications for antibiotic therapy. J Infect. 1996 Jul. 33(1):47-8. [View Abstract]
  61. Rabkin JM, Orloff SL, Corless CL, et al. Hepatic allograft abscess with hepatic arterial thrombosis. Am J Surg. 1998 May. 175(5):354-9. [View Abstract]
  62. Rahimian J, Wilson T, Oram V. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004 Dec 1. 39(11):1654-9.
  63. Rajak CL, Gupta S, Jain S, et al. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR Am J Roentgenol. 1998 Apr. 170(4):1035-9. [View Abstract]
  64. Rintoul R, O'Riordain MG, Laurenson IF, et al. Changing management of pyogenic liver abscess. Br J Surg. 1996 Sep. 83(9):1215-8. [View Abstract]
  65. Rubin RH, Swartz MN, Malt R. Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. Am J Med. 1974 Oct. 57(4):601-10. [View Abstract]
  66. Sabbaj J. Anaerobes in liver abscess. Rev Infect Dis. 1984 Mar-Apr. 6 Suppl 1:S152-6. [View Abstract]
  67. Sabbaj J, Sutter VL, Finegold SM. Anaerobic pyogenic liver abscess. Ann Intern Med. 1972 Oct. 77(4):627-38. [View Abstract]
  68. Seeto RK, Rockey DC. Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore). 1996 Mar. 75(2):99-113. [View Abstract]
  69. Serste T, Bourgeois N, Vanden Eynden F, et al. Endoscopic drainage of pyogenic liver abscesses with suspected biliary origin. Am J Gastroenterol. 2007 Jun. 102(6):1209-15. [View Abstract]
  70. Sheinfeld AM, Steiner AE, Rivkin LB, et al. Transcutaneous drainage of abscesses of the liver guided by computed tomography scan. Surg Gynecol Obstet. 1982 Nov. 155(5):662-6. [View Abstract]
  71. Soni PN, Hoosen AA, Pillay DG. Hepatic abscess caused by Salmonella typhi. A case report and review of the literature. Dig Dis Sci. 1994 Aug. 39(8):1694-6. [View Abstract]
  72. Sparberg M, Gottschalk A, Kirsner JB. Liver abscess complication regional enteritis: report of two cases. Gastroenterology. 1965 Nov. 49(5):548-51. [View Abstract]
  73. Strungs I, Farrell DJ, Matar LD, et al. Multiple hepatic abscesses due to Yersinia enterocolitica. Pathology. 1995 Oct. 27(4):374-7. [View Abstract]
  74. Sugano S, Matuda T, Suzuki T, et al. Hepatic actinomycosis: case report and review of the literature in Japan. J Gastroenterol. 1997 Oct. 32(5):672-6. [View Abstract]
  75. Tachopoulou OA, Vogt DP, Henderson JM, et al. Hepatic abscess after liver transplantation: 1990-2000. Transplantation. 2003 Jan 15. 75(1):79-83. [View Abstract]
  76. Tan Y, Chung AY, Chow PK et al. An Appraisal of Surgical and Percutaneous Drainage for Pyogenic Liver Abscesses Larger than 5 cm. Annals of Surgery. 2005. 241:485-490.
  77. Tazawa J, Sakai Y, Maekawa S, et al. Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage. Am J Gastroenterol. 1997 Feb. 92(2):271-4. [View Abstract]
  78. Thaler M, Pastakia B, Shawker TH, et al. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med. 1988 Jan. 108(1):88-100. [View Abstract]
  79. Thomas PG, Ravindra KV. Amebiasis and biliary infection. Surgery of the Liver and Biliary Tract. 2000. 1147-1166.
  80. Townsend CM, Beuchamp RD, Evers BM. The liver. Sabiston Textbook of Surgery. 17th ed. 2004. 1513-1567.
  81. Trump DL, Fahnestock R, Cloutier CT, et al. Anaerobic liver abscess and intrahepatic metastases: a case report and review of the literature. Cancer. 1978 Feb. 41(2):682-6. [View Abstract]
  82. Tsui BC, Mossey J. Occult liver abscess following clinically unsuspected ingestion of foreign bodies. Can J Gastroenterol. 1997 Jul-Aug. 11(5):445-8. [View Abstract]
  83. Vakil N, Hayne G, Sharma A, et al. Liver abscess in Crohn's disease. Am J Gastroenterol. 1994 Jul. 89(7):1090-5. [View Abstract]
  84. Vallejo JG, Stevens AM, Dutton RV, et al. Hepatosplenic abscesses due to Brucella melitensis: report of a case involving a child and review of the literature. Clin Infect Dis. 1996 Mar. 22(3):485-9. [View Abstract]
  85. Vukmir RB. Pyogenic hepatic abscess. Am Fam Physician. 1993 May 1. 47(6):1435-41. [View Abstract]
  86. Wells CD, Arguedas M. Amebic liver abscess. South Med J. 2004 Jul. 97(7):673-82.
  87. Wong E, Khardori N, Carrasco CH, et al. Infectious complications of hepatic artery catheterization procedures in patients with cancer. Rev Infect Dis. 1991 Jul-Aug. 13(4):583-6. [View Abstract]
  88. Yang DM, Kim HN, Kang JH. Complications of pyogenic hepatic abscess: computed tomography and clinical features. J Comput Assist Tomogr. 2004 May-Jun. 28(3):311-7.
  89. Yeh TS, Ho YP, Jan YY, et al. Efficacy of color sonography and harmonic scalpel in laparoscopic management of multiple/lobulated liver cysts and abscesses. Hepatogastroenterology. 2007 Mar. 54(74):485-8. [View Abstract]
  90. Yeh TS, Jan YY, Jeng LB, et al. Pyogenic liver abscesses in patients with malignant disease: a report of 52 cases treated at a single institution. Arch Surg. 1998 Mar. 133(3):242-5. [View Abstract]
  91. Yoshida M, Mitsuo M, Kutsumi H, et al. A successfully treated case of multiple liver abscesses accompanied by portal venous gas. Am J Gastroenterol. 1996 Nov. 91(11):2423-5. [View Abstract]

Table 4: Underlying etiology of 1086 cases of liver abscess compiled from the literature.

Table 2: Microbiologic results from 312 cases of liver abscess compiled from the literature.

Table 1: Presenting symptoms and signs in 715 patients diagnosed with liver abscess.

Table 3: Comparison of the radiologic procedures used in the diagnosis of liver abscess.

Computed tomography (CT) scan findings of liver abscess are shown. A large, septated abscess of the right hepatic lobe is revealed. Abscess was successfully treated with percutaneous drainage and antimicrobial therapy.

Computed tomography (CT) scan findings of liver abscess are shown. A large anterior abscess involving the left hepatic lobe is revealed. Abscess was successfully treated with percutaneous drainage and antimicrobial therapy.

Table 1: Presenting symptoms and signs in 715 patients diagnosed with liver abscess.

Table 2: Microbiologic results from 312 cases of liver abscess compiled from the literature.

Table 3: Comparison of the radiologic procedures used in the diagnosis of liver abscess.

Table 4: Underlying etiology of 1086 cases of liver abscess compiled from the literature.

Computed tomography (CT) scan findings of liver abscess are shown. A large, septated abscess of the right hepatic lobe is revealed. Abscess was successfully treated with percutaneous drainage and antimicrobial therapy.

Computed tomography (CT) scan findings of liver abscess are shown. A large anterior abscess involving the left hepatic lobe is revealed. Abscess was successfully treated with percutaneous drainage and antimicrobial therapy.